Arcoxia as Effective as Ibuprofen

JUNE 01, 2005

A study from Merck Laboratories has shown cyclooxygenase-2 (COX-2) inhibitor etoricoxib (Arcoxia) to be as effective as ibuprofen for treating pain associated with arthritis. The 12-week study included 528 patients being treated for arthritis of the hip and knee and compared Arcoxia with ibuprofen and placebo.

It took about 2 weeks for Arcoxia and ibuprofen to achieve maximum effectiveness, with symptom control lasting for another 10 weeks. Both drugs performed better than placebo and generally were well tolerated. Arcoxia is a new COX-2 inhibitor and, as such, has been scrutinized by the FDA along with Vioxx and other members of that class of drugs for a possible link to heart attack and stroke.



SHARE THIS SHARE THIS
0
Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.